Impact of spacer use on the efficacy and safety of ciclesonide MDI in children with persistent asthma

S. Pedersen, S. Hirsch, R. Engelstätter, P. Potter, S. Dachev, J. Kaczmarek (Kolding, Denmark; Konstanz, Germany; Cape Town, South Africa; Ruse, Bulgaria; Lodz, Poland)

Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues
Session: Drug treatment of childhood asthma: the controversies and the issues
Session type: Thematic Poster Session
Number: 1220
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Pedersen, S. Hirsch, R. Engelstätter, P. Potter, S. Dachev, J. Kaczmarek (Kolding, Denmark; Konstanz, Germany; Cape Town, South Africa; Ruse, Bulgaria; Lodz, Poland). Impact of spacer use on the efficacy and safety of ciclesonide MDI in children with persistent asthma. Eur Respir J 2009; 34: Suppl. 53, 1220

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The efficacy and safety formoterol-HFA pMDI in school children with persistent asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 460s
Year: 2007

Efficacy, safety and acceptance of salbutamol administered via MAGhaler in children with mild to moderate asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 430s
Year: 2002

Safety and efficacy of formoterol delivered via a novel DPI device in children with asthma
Source: Annual Congress 2010 - Paediatric asthma, rhinitis and management
Year: 2010


Effectiveness and safety of fluticasone propionate/salmeterol 250/50mcg administered once daily to patients with persistent asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 309s
Year: 2004

Efficacy and safety of new formulation of fluticasone propionate/salmeterol delivered via a HFA pMDI inhaler in patients with asthma
Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Year: 2020


Evaluation of acceptability, efficacy and safety of a novel dry powder inhaler in patients with persistent asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 70s
Year: 2007

Device preference and efficacy of formoterol aerolizer and salbutamol MDI in children with asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 134s
Year: 2003

Efficacy and safety of ciclesonide compared with fluticasone propionate or budesonide in adolescent patients with persistent asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 458s
Year: 2007

Treatment of acute severe asthma with formoterol Turbuhaler provides a similar effect on patients' well-being as salbutamol by pMDI plus spacer
Source: Eur Respir J 2002; 20: Suppl. 38, 47s
Year: 2002

Long-term safety and efficacy of budesonide/formoterol in Japanese patients with asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II
Year: 2008

Efficacy, safety and cost of using beclomethason dipropionate in patients with persistent moderate bronchial asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 124s
Year: 2004

Comparative efficacy and costs of the treatment of moderate to severe persistent asthma with a new dry-powder inhaled beclomethasone dipropionate and formoterol combination
Source: Annual Congress 2013 –Health economics of airway diseases
Year: 2013


Efficacy and safety of long-term therapy with Salamol combined with Beclason versus Salamol only in patients with mild persistent asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 42s
Year: 2002

Comparison of efficacy and safety of Obucort Swinghaler with Pulmicot Turbuhaler in mild to moderate severe asthma patients
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I
Year: 2010

Efficacy and safety of fluticasone/formoterol compared to fluticasone alone in patients with asthma
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012

Efficacy and tolerability of formoterol Turbuhaler in 6–11 year old children with asthma, not adequately controlled with inhaled corticosteroids
Source: Eur Respir J 2002; 20: Suppl. 38, 430s
Year: 2002

Efficacy and safety of budesonide/formoterol comparing with budesonide and theophylline in Japanese adult patients with asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008

Long-term safety of inhaled formoterol in adult asthma patients
Source: Annual Congress 2009 - Aspects of clinical asthma
Year: 2009

Efficacy and safety of transdermal tulobuterol (LABA) on asthma patients
Source: Annual Congress 2007 - New treatments for asthma
Year: 2007


Efficacy of long-term formoterol therapy vs as-needed salbutamol use in patients with moderate asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 426s
Year: 2001